Packagers for Hire - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Packagers for Hire
Outsourcing packaging functions can save time and money.

Pharmaceutical Technology
Volume 34, Issue 12, pp. 32-34

Unique packaging options

Some contract packagers offer custom designs, and several vendors have developed proprietary unit-dose delivery systems. One such system consists of a foam applicator pad backed by a small pouch, which is squeezed to break a frangible inner seal and release the product into the pad. Suitable for creams, ointments, and lotions, the system is available in 0.5- and 1-g sizes (DelPouch single-use pack, Catalent).

Another proprietary system is a scored, four-side-sealed pouch that permits one-handed dispensing of creams, gels, pastes, or lotions. Capable of holding 0.5 to 17 mL, the pouch dispenses the product when the user pushes two of its ends together to break the score (Snap! single-use pack, Tapemark). The pouch also can be equipped with a flat or pop-up applicator pad (Snapplicator) and configured to provide a series of doses or to deliver dual-component products.

Custom designs for solid dosage forms include wallet-pack configurations that support patient compliance and impart child-resistant and senior-friendly features to traditional blisters (Shellpak unit-dose medication packaging, MeadWestvaco, Richmond, VA, filled by Reed-Lane).

State-of-the-art equipment

Contract packagers constantly upgrade their operations to meet the ever-changing requirements of their customers. One firm's strategy involves making plans to expand as soon as an existing bottling, stick pack, or blister-packaging line is running at 50% capacity. When the line reaches 75% capacity, the expansion plan is activated. "We never want to operate at higher than 75% capacity so we always have room to grow with our customers," says Dupont. "We never want to be the constraint on growth. We want to be able to take on a new project or accommodate a surge in demand," he explains.

As a result, the company recently installed a stick-pack system that precisely fills 10 packs at a time with volumes from 180 mg to 3 g at speeds as high as 1000/min (Ropack). The equipment is installed in a Class 100,000 environment with controls that permit filling under conditions of 30% relative humidity. If needed, a nitrogen flush before sealing can reduce residual oxygen in the package headspace to less than 2%.

Another firm recently installed two blister lines and built a secondary packaging line in Europe for nasal strips (Catalent). The lines address growing demand for these packaging formats and products.

Another new installation involves a high-speed pouching machine that forms, fills, and seals four-side-seal pouches (Reed-Lane). It also produces multiple packs per cycle.

Contract packager needs

Pharmaceutical companies decide not to outsource a function if it requires customized equiment or if outsourcing is perceived as risky, But brand owners considering contract packaging need to be prepared to provide the information and support needed for a successful collaboration. It's particularly important to define critical quality attributes early in the process. "Having that dialogue up front is essential," says Larsen.

Contract packagers also need a clear description of the nature and scope of the project, product samples, drawings, Material Safety Data Sheet information, primary and secondary packaging material specifications, lot size, forecasts, and special requirements such as temperature or humidity levels.

Luke says, "Our customer service and project management people go through a detailed checklist." This information sharing helps ensure that the project proceeds smoothly.

Dupont concludes, "A master service agreement regulates all of our business dealings. The second document we rely on is a quality agreement that lays out in detail how we manage and report quality."

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here